4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-059986
EVP and Chief Business Officer bought 4,270 shares at $4.68 ($19,984)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MAUNEY DAVID M MD EVP and Chief Business Officer | 2017-11-08 | Purchase | +4,270 | $4.68 | $19,984 | 58,662 | D |
| Open-market purchases · 4,270 sh · avg $4.68 · $19,984 | |||||||
Loading xslF345X03/doc4.xml…